Showing results (21-30 of 116) with videos related to

Sort By:
Pageof 12
Current Cancer Drug Targets|December 17, 2008
The PIK3CA gene as a mutated target for cancer therapyJohn P Gustin, David P Cosgrove, Ben Ho Park
Breast Cancer Research and Treatment|February 13, 2017
PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneitySarah Croessmann, Hong Yuen Wong, Daniel J Zabransky, et al.
Breast Cancer Research and Treatment|December 12, 2019
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic propertiesKelly Kyker-Snowman, Robert M Hughes, Christopher L Yankaskas, et al.
Cancer Research|June 19, 2013
mTOR signaling feedback modulates mammary epithelial differentiation and restrains invasion downstream of PTEN lossSusmita Ghosh, Lidenys Varela, Akshay Sood, et al.
Oncotarget|July 6, 2015
AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancerTeraneh Z Jhaveri, Juhyung Woo, Xiaobin Shang, et al.
Breast Cancer Research and Treatment|December 19, 2018
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapiesBerry Button, Sarah Croessmann, David Chu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 8, 2020
Undetectable Tumor Cell-Free DNA in a Patient With Metastatic Breast Cancer With Complete Response and Long-Term RemissionNatasha Hunter, Sarah Croessmann, Karen Cravero, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2015
NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stabilitySarah Croessmann, Hong Yuen Wong, Daniel J Zabransky, et al.
Pageof 12